Source: Eur Respir J 2016; 47: 1152-1161
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Koren Dorit, Gozal David, Philby Mona F., Bhattacharjee Rakesh, Kheirandish-Gozal Leila. Impact of obstructive sleep apnoea on insulin resistance in nonobese and obese children. Eur Respir J 2016; 47: 1152-1161

Member's Comments

No comment yet.

Related content which might interest you: The association of obstructive sleep apnea with insulin resistance in obese Egyptians Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases Year: 2019 Triglyceride-glucose index in non-diabetic, non-obese patients with obstructive sleep apnoea Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea Year: 2021 Risk of obstructive sleep apnea and impaired glucose metabolism in non-diabetic subjects Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019 Clinical predictors of obesity hypoventilation syndrome in morbidly obese subjects with obstructive sleep apnoea Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I Year: 2015 In vitro genioglossus function is different in obese and non-obese patients with obstructive sleep apnea Source: Eur Respir J 2001; 18: Suppl. 33, 332s Year: 2001 Chronic hypercapnia in morbidly obese patients with obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005 Is obstructive sleep apnoea (OSA) associated with insulin resistance (IR) in severely obese adults? Source: Annual Congress 2003 - Systematic inflammation and metabolic disorders in sleep related breathing disorders Year: 2003 Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome Source: Eur Respir J 2003; 22: 156-160 Year: 2003 Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients Source: Eur Respir J 2004; 24: Suppl. 48, 447s Year: 2004 Impact of obstructive sleep apnoea (OSA) on glucose metabolism Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007 Insulin resistance in obstructive sleep apnea patients Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010 Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients Source: Eur Respir J 2008; 31: 223-225 Year: 2008 Relationship between upper airway and obstructive sleep apnea-hypopnea syndrome in morbidly obese women Source: Eur Respir J 2006; 28: Suppl. 50, 199s Year: 2006 The upper airway and obstructive sleep apnea in morbidly obese women Source: Eur Respir J 2004; 24: Suppl. 48, 119s Year: 2004 Body composition in obese males with obstructive sleep apnea (OSA) Source: Eur Respir J 2004; 24: Suppl. 48, 572s Year: 2004 The effect of 12-month growth hormone treatment on obstructive sleep apnoea in abdominally obese men Source: Annual Congress 2008 - Alternatives for continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2008 The inflammation and insulin resistance in obstructive sleep apnea Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Serum leptin levels in obese patients with severe obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004 Cardiovascular and metabolic effects of CPAP in obese males with OSA Source: Eur Respir J 2007; 29: 720-727 Year: 2007 Impact of sleep onset on hemodynamic parameters in obese patients with or without obstructive sleep apnea Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers Year: 2017